BioInformant

Your Global Leader in Stem Cell Market Research

Home » parkinson's disease

Stem Cell Treatment for Parkinson’s Disease

By

At least 16 clinical trials and one physician-led study in Japan are exploring stem cells for Parkinson’s disease. Some of these trials are using stem cells as living therapies, while others are using stem cells to study causes of the disease and its progression.

This research progress is critical, because Parkinson’s disease debilitates the body and causes tremors and numbness, loss of motor function, and stooping. Eventually, left untreated, Parkinson’s disease leads to death. The good news is, researchers are showing significant results in their studies on the link between stem cells and Parkinson’s disease.

In this article:

  1. An Introduction to Stem Cells
  2. What Are Stem Cells?
  3. What Is Parkinson’s Disease?
  4. How Does Stem Cell Therapy Work?
  5. How Can Stem Cells Help Heal This Condition?
  6. Are We Close to a Widespread Solution?

[Read more…]

Parkinson’s Disease Treatment Using Reprogrammed Stem Cells

By

Anyone who has ever watched a friend or loved one succumb to the slow degradation of Parkinson’s disease will understand the urge to cure it. Read on to learn more about how stem cells could be a possible treatment option for Parkinson’s disease.

In this article:

[Read more…]

Parkinson’s Disease Clinical Trial to Launch in Japan | iPS Cell Trial

By

Japan will continue its dominance with iPS cell clinical trials with the launch of a physician-lead trial for Parkinson’s disease. In its July 2018 press announcement, Kyoto University announced that its University Hospital and the Center for iPS Cell Research and Application (CiRA) will launch the world’s first clinical trial for Parkinson’s disease to utilize an induced pluripotent stem cell (iPS cell) derived therapeutic product.

Existing iPS Cell Trials

This newest iPS cell trial represents only the third iPS cell trial to be undertaken worldwide. The other existing iPS cell trials are being conducted by the RIKEN Center for Developmental Biology (CDC) and Cynata Therapeutics (ASX:CYP), respectively. [Read more…]

Kyoto University to Launch iPS Cell Clinical Trial for Parkinson’s Disease

By

July 30, 2018 (Kyoto, Japan) – Kyoto University Hospital, in partnership with the Center for iPS Cell Research and Application (CiRA), Kyoto University, has planned physician-initiated clinical trials for Parkinson’s disease that transplants dopaminergic progenitors1 generated from induced pluripotent stem (iPS) cells. The clinical trial notification was submitted to the Pharmaceutical and Medical Devices Agency (PMDA; the Japanese equivalent of the FDA) on June 4, 2018, and the clinical trials are scheduled to begin on August 1 this year. [Read more…]

BioInformant's World-Class Clients